1. Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation
   Micah G. Donovan et al, 2020, British Journal of Pharmacology CrossRef
2. Circulating Biomarkers in Breast Cancer
   Katelyn N Seale et al, 2022, Clinical Breast Cancer CrossRef
3. RASSF1A: A promising target for the diagnosis and treatment of cancer
   Yuling Bin et al, 2020, Clinica Chimica Acta CrossRef
4. Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women
   Thangarajan Rajkumar et al, 2022, Scientific Reports CrossRef
5. Dkk1 as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Breast Cancer Patients
   Mariz Kasoha et al, 2024, Cancers CrossRef
6. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
   Cora Palanca-Ballester et al, 2021, Cancers CrossRef
7. Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis
   Mingyi Li et al, 2019, Bioscience Reports CrossRef
8. Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
   L. M. Janssen et al, 2024, npj Breast Cancer CrossRef
9. The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy
   Naiade Calanca et al, 2019, Epigenetics CrossRef
10. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients
    Tatiana M. Zavarykina et al, 2023, International Journal of Molecular Sciences CrossRef